Effect of VR Versus CT in Sensorimotor Function of Upper Extremity in Chronic Stroke Patients
Effect of Virtual Reality Versus Conservative Treatment in Sensorimotor Function of Upper Extremity in Chronic Stroke Patients
1 other identifier
interventional
33
1 country
1
Brief Summary
Virtual reality (VR) therapy has shown promising results in improving sensorimotor function of the upper extremity in chronic stroke patients compared to conservative treatments. VR offers immersive, interactive environments that can enhance motivation and engagement in rehabilitation exercises.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 30, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2024
CompletedFirst Submitted
Initial submission to the registry
August 21, 2024
CompletedFirst Posted
Study publicly available on registry
August 23, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
October 30, 2024
CompletedAugust 23, 2024
August 1, 2024
7 months
August 21, 2024
August 21, 2024
Conditions
Outcome Measures
Primary Outcomes (2)
Fugl-Meyer Assessment (FMA) for Upper Extremity
The Fugl-Meyer Assessment (FMA) for Upper Extremity is a widely used and validated tool to evaluate motor function, balance, sensation, and joint functioning in individuals who have had a stroke. It specifically assesses the sensorimotor function of the upper extremities. Scoring: The upper extremity section of the FMA includes 33 items, each scored on a scale of 0 to 2: 0: Cannot perform 1. Performs partially 2. Performs fully The maximum score for the upper extremity section is 66, indicating optimal function.
12 Months
Stroke Impact Scale (SIS)
The Stroke Impact Scale (SIS) is a self-report questionnaire that evaluates the impact of stroke on multiple dimensions, including strength, hand function, activities of daily living (ADL), mobility, communication, emotion, memory, thinking, and participation. Each item is scored on a scale of 1 to 5: 1: Unable to do 5: Not difficult at all Higher scores indicate a lesser impact of stroke on the patient's life.
12 months
Study Arms (2)
Exp Group
EXPERIMENTALControl Group
ACTIVE COMPARATORInterventions
Intervention: Patients in this group will receive therapy using VR technology. This involves engaging in various sensorimotor training exercises and tasks in an immersive virtual environment. The VR sessions are designed to be interactive and adaptive, providing real-time feedback to the user. The exercises will target the improvement of motor functions, coordination, and strength of the affected upper extremity. Duration and Frequency: The specific regimen may involve sessions several times a week, with each session lasting between 30 to 60 minutes, over a period of several weeks or months, depending on the study design.
Intervention: Patients in this group will receive traditional rehabilitation therapies, which may include: Physical Therapy (PT): Exercises and activities aimed at improving strength, flexibility, and coordination of the upper limb. Occupational Therapy (OT): Functional task training to enhance daily living skills and independence, focusing on the use of the upper extremity. Manual Therapy: Techniques such as massage or joint manipulation to improve mobility and reduce pain. Home Exercise Programs: Prescribed exercises to be performed at home to reinforce therapy sessions. Duration and Frequency: Similar to the VR group, this regimen may involve regular sessions several times a week, with each session lasting between 30 to 60 minutes, over a comparable period.
Eligibility Criteria
You may qualify if:
- Patients with a confirmed diagnosis of chronic stroke (at least 6 months post-stroke).
- Age:
- Upper Extremity Impairment:
- Ability to provide informed consent to participate in the study.
You may not qualify if:
- Severe communication difficulties that would impede the ability to follow instructions during therapy.
- Severe spasticity in the affected upper limb (Modified Ashworth Scale score of 4 or higher).
- Other Neurological Conditions
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Services Hospital,Shadman 1
Lahore, Punjab Province, Pakistan
MeSH Terms
Interventions
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
August 21, 2024
First Posted
August 23, 2024
Study Start
November 30, 2023
Primary Completion
July 1, 2024
Study Completion
October 30, 2024
Last Updated
August 23, 2024
Record last verified: 2024-08
Data Sharing
- IPD Sharing
- Will not share